Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated

Br J Dermatol. 2021 Apr;184(4):755-757. doi: 10.1111/bjd.19631. Epub 2021 Feb 28.

A V Sears¹, R T Woolf¹, E Gribaleva^{1

2}, W Abdelrahman¹, S Robbie³, B Menon⁴, B Kirkham⁴, C H Smith^{1

5}, A E Pink¹

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
² I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
³ Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁴ Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁵ St John's Institute of Dermatology, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.

No abstract available

Publication types